79.31
79.31 (0%)
As of Feb 14, 2025
Insmed Inc [INSM]
Source:
Company Overview
Insmed Inc is a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases.
| Country | United States |
| Headquarters | bridgewater |
| Phone Number | (908) 977-9900 |
| Industry | manufacturing |
| CEO | William H. Lewis |
| Website | http://www.insmed.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $363.7 |
| Operating Profit | $-878.3 |
| Net Income | $-913.8 |
| Net Cash | $72.7 |
Profit Ratios
| Gross Margin | $278 |
| Operating Margin | -241.5 |
| Profit as % of Revenues | -30.4% |
| Profit as % of Assets | -54.5% |
| Profit as % of Stockholder Equity | -320.2% |
Management Effectiveness
| Return on Equity | -320.2% |
| Return on Assets | -45.1% |
| Turnover Ratio | 21.7% |
| EBITA | $-873.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $2,025.2 |
| Total Liabilities | $1,739.9 |
| Operating Cash Flow | $-683.9 |
| Investing Cash Flow | $-583.2 |
| Financing Cash Flow | $1,341 |
